#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovitis Hereditary hypophosphataemic rickets Depression NTRK gene fusion overexpression Myxoid liposarcoma Acute myeloid leukaemia refractory Liposarcoma metastatic Friedreich's ataxia Mantle cell lymphoma stage III Aplastic anaemia Epstein-Barr virus infection Infection in an immunocompromised host Hypoparathyroidism Gestational trophoblastic tumour Leiomyosarcoma More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Basic Information Thrombotic thrombocytopenic purpura – Life with Disease Friedreich’s ataxia Mantle cell lymphoma stage II – Treatment Splenic marginal zone lymphoma – Diagnostics Optic glioma – Diagnostics Rhabdomyosarcoma Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Hereditary neuropathic amyloidosis – Treatment Pulmonary fibrosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ivospemin AAV9-CTNT-COBAG3 Pramlintide Acetate Sonelokimab [18F]Alf-Nota-Octreotide Zinc Sulphate Heptahydrate Lisocabtagene Maraleucel Sodium Ascorbate Xaluritamig Ficlatuzumab SEVUPARIN Hypromellose Gentamicin Sulfate Cefoxitin Sodium Aluminium Oxide Tralokinumab Atuliflapon Narsoplimab Mercaptamine Transcon Il-2Β/Γ More therapies…

    Learn about Your Condition

    Mite allergy Skin neoplasm excision Pulmonary sarcoidosis Hypochromic anaemia Malignant lymphoid neoplasm Choroidal dystrophy Rheumatic disorder Factor IX deficiency Juvenile absence epilepsy Angelman's syndrome Laparoscopic surgery Dementia Procedural anxiety Fracture infection Conjunctivitis allergic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of momelotinib in patients with VEXAS syndrome and myelodysplastic syndrome who are dependent on or do not respond to steroid treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • VEXAS syndrome
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Momelotinib Dihydrochloride Monohydrate
    France

  • Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Embolism venous
    Investigated Drugs:
    • SRSD107
    • Enoxaparin Sodium
    Bulgaria Czechia Hungary Latvia Lithuania Poland

  • Study of RSV vaccine immune response persistence and revaccination safety in adult lung and kidney transplant recipients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Germany Italy Spain

  • Study of lidocaine with epinephrine and sodium bicarbonate compared to lidocaine with epinephrine alone for local anesthesia in hand and foot surgery patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Epinephrine Bitartrate
    • Sodium Hydrogen Carbonate
    • Lidocaine Hydrochloride
    France

  • Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

    Recruiting

    4 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Pembrolizumab
    Austria Belgium Czechia France Germany Greece +5

  • Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Epirubicin
    • Tamoxifen
    • Anastrozole
    Belgium France Greece Ireland Italy Poland +1
Previous Page
1 … 142 143 144 145 146 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!